ReviewPublished 9 October 2026Progress on therapeutic mRNA vaccines for cancerSiyu Wu · Huarong Liao · Wei ZhangFrontiers in Oncologydoi 10.3389/fonc.2026.1980190
Original ResearchPublished 18 September 2026A novel minimally humanized mouse model of aniridia for preclinical evaluation of CRISPR gene editing strategiesSeyedeh Zeinab Mirjalili Mohanna · Andrea J. Korecki · Pardis Kazemian · Tess C. Lengyell · Bethany A. Adair · Blair R. Leavitt · Elizabeth M. SimpsonFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1910209
Original ResearchPublished 16 September 2026Overcoming delivery barriers of large all-in-one CRISPR/Cas9 plasmids using lysine-based lipid nanoparticlesWenhan Sung · Tianshu Li · Shinji TakeokaFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1888079
Brief Research ReportPublished 15 September 2026R2Tg retrotransposon mediated targeted integration of exogenous genes into the 28S rDNA locus in mammalian cell lines for PKU gene therapyXiuyuan Wang · Ziqi Wen · Rongjun Xu · Wenjing Shi · Yiling Long · Xingri Zhan · Rui Su · Jia Fei · Yumin LiFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1893815
Mini ReviewPublished 25 June 2026The application of CRISPR gene-editing technology in influenza prevention and controlXinyi Zhang · Hangyi Shi · Jianlan Yang · Lailing Du · Xinling Zhang · Xiaoping LiFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1844919
ReviewPublished 14 April 2026Advancements in polymer- and lipid-based nanoparticles for enhancing drug solubility, stability, and bioavailability: an integrative and forward-looking reviewRishika ChauhanFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1801422
Systematic ReviewPublished 1 April 2026Nanoparticle-mediated mRNA delivery for cancer, autoimmunity, and genetic diseases: a rapid reviewOkechukwu Paul-Chima Ugwu · Fabian C. Ogenyi · Mariam Basajja · Chinyere N. Ugwu · Mundu M. Mustafa · Michael Ben OkonFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1793322
Original ResearchPublished 13 January 2026Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cellsRiya Khetan · Weranga Rajapaksha · Bukuru D. Nturubika · Todd A. Gillam · Doug A. Brooks · Sanjay Garg · Anton Blencowe · Hugo Albrecht · Preethi EldiFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1727958
